Cloning and Functional Characterization of HDAC11, a Novel Member of the Human Histone Deacetylase Family
Open accessThe DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Abstract
We have cloned and characterized a human cDNA that belongs to the histone deacetylase family, which we designate as HDAC11. The predicted HDAC11 amino acid sequence reveals an open reading frame of 347 residues with a corresponding molecular mass of 39 kDa. Sequence analyses of the putative HDAC11 protein indicate that it contains conserved residues in the catalytic core regions shared by both class I and II mammalian HDAC enzymes. Putative orthologues of HDAC11 exist in primate, mouse, Drosophila, and plant. Epitope-tagged HDAC11 protein expressed in mammalian cells displays histone deacetylase activity in vitro. Furthermore, HDAC11's enzymatic activity is inhibited by trapoxin, a known histone deacetylase inhibitor. Multiple tissue Northern blot and real-time PCR experiments show that the high expression level of HDAC11 transcripts is limited to kidney, heart, brain, skeletal muscle, and testis. Epitope-tagged HDAC11 protein localizes predominantly to the cell nucleus. Co-immunoprecipitation experiments indicate that HDAC11 may be present in protein complexes that also contain HDAC6. These results indicate that HDAC11 is a novel and unique member of the histone deacetylase family and it may have distinct physiological roles from those of the known HDACs.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Two related classes of eukaryotic zinc-containing HDACs have been recognized based upon sequence similarity: class I (HDAC1, 2, 3, and 8) and class II (HDAC4, 5, 6, 7, 9, and 10) (Johnstone, 2002; Gao et al., 2002).”
From Structural Snapshots of Human HDAC8 Provide Insights into the Class I Histone Deacetylases (2004) · cites this paper as Gao et al., 2002
In the citing paper
“It has been shown to associate with HDAC6 (Gao et al., 2002; Cheng et al., 2014)”
From Histone deacetylase 11 is an ε-N-Myristoyllysine hydrolase (2018) · cites this paper as Gao et al., 2002
In the citing paper
“HDAC11 is a newly identified member of the HDAC family and thus far no known physiological function for HDAC11 has been demonstrated23.”
From The histone deacetylase HDAC11 regulates the expression of interleukin 10 and immune tolerance (2009) · cites this paper as [23]
Citations
Cites
Crystal structure of the nucleosome core particle at 2.8 Å resolution
Luger, K., Mäder, A. W., Richmond, R. K., Sargent, D. F., & Richmond, T. J. (1997) · Nature · doi:10.1038/38444 · Cited by 9,466
Transcriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase
Imai, S.-I., Armstrong, C. M., Kaeberlein, M., & Guarente, L. (2000) · Nature · doi:10.1038/35001622 · Cited by 3,510
Roth, S. Y., Denu, J. M., & Allis, C. D. (2001) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.70.1.81 · Cited by 1,845
A Mammalian Histone Deacetylase Related to the Yeast Transcriptional Regulator Rpd3p
Taunton, J., Hassig, C. A., & Schreiber, S. L. (1996) · Science · doi:10.1126/science.272.5260.408 · Cited by 1,829
Histone acetylation and transcriptional regulatory mechanisms
Struhl, K. (1998) · Genes & Development · doi:10.1101/gad.12.5.599 · Cited by 1,815
Structures of a histone deacetylase homologue bound to the TSA and SAHA inhibitors
Finnin, M. S., Donigian, J. R., Cohen, A., Richon, V. M., Rifkind, R. A., Marks, P. A., Breslow, R., & Pavletich, N. P. (1999) · Nature · doi:10.1038/43710 · Cited by 1,714
Nuclear Receptor Repression Mediated by a Complex Containing SMRT, mSin3A, and Histone Deacetylase
Nagy, L., Kao, H.-Y., Chakravarti, D., Lin, R. J., Hassig, C. A., Ayer, D. E., Schreiber, S. L., & Evans, R. M. (1997) · Cell · doi:10.1016/s0092-8674(00)80218-4 · Cited by 1,230
Duration of Nuclear NF-κB Action Regulated by Reversible Acetylation
Chen, L.-F., Fischle, W., Verdin, E., & Greene, W. C. (2001) · Science · doi:10.1126/science.1062374 · Cited by 1,222
Signal-dependent nuclear export of a histone deacetylase regulates muscle differentiation
McKinsey, T. A., Zhang, C.-L., Lu, J., & Olson, E. N. (2000) · Nature · doi:10.1038/35040593 · Cited by 1,052
Deacetylation of p53 modulates its effect on cell growth and apoptosis
Luo, J., Su, F., Chen, D., Shiloh, A., & Gu, W. (2000) · Nature · doi:10.1038/35042612 · Cited by 818
Research works printed but not linked: 2
- Van Lint, 1996, Gene Expr., 5, 245
- Fischle, 2001, Biochem. Cell Biol., 79, 337, 10.1139/o01-116 · DOI · Paper page
Cited by
Items 101–200 of 761
Negative regulation of histone deacetylase 8 activity by cyclic AMP-dependent protein kinase A
Lee, H., Rezai-Zadeh, N., & Seto, E. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.2.765-773.2004 · Cited by 153
“of both class I and II HDAC enzymes (15).”
BackgroundRecent advances in the discovery of potent and selective HDAC6 inhibitors
Wang, X.-X., Wan, R.-Z., & Liu, Z.-P. (2018) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2017.10.040 · Cited by 152
Epigenetics and airways disease
Adcock, I. M., Ford, P., Ito, K., & Barnes, P. J. (2006) · Respiratory Research · doi:10.1186/1465-9921-7-21 · Cited by 152
“Just as acetylation of histones is associated with gene induction, removal of acetyl groups by histone deacetylases (HDAC)s is generally associated with re-packing of chromatin and a lack of gene expression or gene silencing [29].”
Thakur, V. S., Gupta, K., & Gupta, S. (2011) · Carcinogenesis · doi:10.1093/carcin/bgr277 · Cited by 152
Histone deacetylase 11 is an ε-N-Myristoyllysine hydrolase
Moreno-Yruela, C., Galleano, I., Madsen, A. S., & Olsen, C. A. (2018) · Cell Chemical Biology · doi:10.1016/j.chembiol.2018.04.007 · Cited by 149
Development of histone deacetylase inhibitors for cancer treatment
Marchion, D., & Münster, P. (2007) · Expert Review of Anticancer Therapy · doi:10.1586/14737140.7.4.583 · Cited by 149
Histone deacetylase inhibitors in hematological malignancies and solid tumors
Chun, P. (2015) · Archives of Pharmacal Research · doi:10.1007/s12272-015-0571-1 · Cited by 158
Roles of Histone Deacetylases and Inhibitors in Anticancer Therapy
Verza, F. A., Das, U., Fachin, A. L., Dimmock, J. R., & Marins, M. (2020) · Cancers · doi:10.3390/cancers12061664 · Cited by 143
“Like HDAC10, HDAC11 was discovered in 2002 [78] and so far they are the least studied and understood HDACs.”
BackgroundThe Histone Deacetylase 9 Gene Encodes Multiple Protein Isoforms
Petrie, K., Guidez, F., Howell, L., Healy, L., Waxman, S., Greaves, M., & Zelent, A. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212935200 · Cited by 147
Histone deacetylase function in CD4+ T cells
Ellmeier, W., & Seiser, C. (2018) · Nature reviews. Immunology · doi:10.1038/s41577-018-0037-z · Cited by 154
Senawong, T., Peterson, V. J., Avram, D., Shepherd, D. M., Frye, R. A., Minucci, S., & Leid, M. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m307477200 · Cited by 146
Characterization of the two catalytic domains in histone deacetylase 6
Zou, H., Wu, Y., Navre, M., & Sang, B. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.12.144 · Cited by 148
Liu, Y., Peng, L., Seto, E., Huang, S., & Qiu, Y. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.371120 · Cited by 142
“Several lines of evidence suggest that HDAC6 can also reside in the nucleus and interact with nuclear proteins, including HDAC11 (9), sumoylated p300 (10), the transcriptional corepressor LCoR, and transcription factors such as NF- B and Runx2 (11).”
BackgroundRegulation of the HIF-1α stability by histone deacetylases
Kim, S.-H., Jeong, J.-W., Park, J., Lee, J.-W., Seo, J., Jung, B.-K., Bae, M.-K., & Kim, K.-W. (2007) · Oncology Reports · doi:10.3892/or.17.3.647 · Cited by 144
Cheng, F., Lienlaf, M., Perez-Villarroel, P., Wang, H.-W., Lee, C., Woan, K., Woods, D., Knox, T., Bergman, J., Pinilla-Ibarz, J., et al. (2014) · Molecular Immunology · doi:10.1016/j.molimm.2014.02.019 · Cited by 140
“Recently, by over-expressing or knocking down specific HDACs in murine and human APCs we found that among all the members of this family of enzymes, the primarily nuclear HDAC11(Gao et al., 2002) is recruited to the IL-10 gene promoter to negatively regulate its expression(Villagra et al.”
The Tale of Protein Lysine Acetylation in the Cytoplasm
Sadoul, K., Wang, J., Diagouraga, B., & Khochbin, S. (2011) · BioMed Research International · doi:10.1155/2011/970382 · Cited by 140
“Finally HDAC11, the only type IV deacetylase, is essentially a nuclear enzyme but can be found in the cytoplasm in latent HIV infected cells [82, 83].”
BackgroundEpigenetic regulation of nervous system development by DNA methylation and histone deacetylation
MacDonald, J. L., & Roskams, A. J. (2009) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2009.04.002 · Cited by 152
HDAC signaling in neuronal development and axon regeneration
Cho, Y., & Cavalli, V. (2014) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2014.03.008 · Cited by 135
Histone Deacetylation: An Important Mechanism in Inflammatory Lung Diseases
Adcock, I. M., Ito, K., & Barnes, P. J. (2005) · COPD Journal of Chronic Obstructive Pulmonary Disease · doi:10.1080/15412550500346683 · Cited by 149
“Just as acetylation of histones is associated with gene induction, removal of acetyl groups by HDACs is generally associated with re-packing of chromatin and a lack of gene expression or gene silencing (69).”
BackgroundChen, Y., Lopez-Sanchez, M., Savoy, D. N., Billadeau, D. D., Dow, G. S., & Kozikowski, A. P. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm701606b · Cited by 132
Waltregny, D., de Leval, L., Glénisson, W., Tran, S. L., North, B. J., Bellahcène, A., Weidle, U. H., Verdin, E. M., & Castronovo, V. (2004) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63320-2 · Cited by 145
Simple histone acetylation plays a complex role in the regulation of gene expression
Fukuda, H., Sano, N., Muto, S., & Horikoshi, M. (2006) · Briefings in Functional Genomics and Proteomics · doi:10.1093/bfgp/ell032 · Cited by 153
“Class I Hos1 Yeast Transcriptional repression/activation [71] Hos2 Yeast Set3C Transcriptional repression [72, 73] Rpd3 Yeast Rpd3S, L Transcriptional repression/activation [71] HDAC1 Mammal mSin3-HDAC, NuRD, Co-REST, N-CoR-2 Transcriptional repression [74, 75] HDAC2 Mammal mSin3-HDAC, NuRD, Co-REST, N-CoR-2 Transcrip…”
BackgroundMethodDeactylase Inhibitors Disrupt Cellular Complexes Containing Protein Phosphatases and Deacetylases
Brush, M. H., Guardiola, A., Connor, J. H., Yao, T.-P., & Shenolikar, S. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m310997200 · Cited by 129
Targeting Histone Deacetylases in Diseases: Where Are We?
Benedetti, R., Conte, M., & Altucci, L. (2015) · Antioxidants & Redox Signaling · doi:10.1089/ars.2013.5776 · Cited by 126
“HDAC11, containing a catalytic domain at the N-terminus, is similar to HDAC3 and 8, suggesting that it might be more closely related to class I than to class II HDACs (71).”
BackgroundInfluentialMolecular signature of oncogenic ras-induced senescence
Mason, D. X., Jackson, T. J., & Lin, A. W. (2004) · Oncogene · doi:10.1038/sj.onc.1208172 · Cited by 127
“There are at least 11 HDACs identified in mammalian cells (Gray and Ekstrom, 2001; Zhou et al., 2001; Gao et al., 2002; Kao et al., 2002).”
BackgroundFunctional Characterization of JMJD2A, a Histone Deacetylase- and Retinoblastoma-binding Protein
Gray, S. G., Iglesias, A. H., Lizcano, F., Villanueva, R., Camelo, S., Jingu, H., Teh, B. T., Koibuchi, N., Chin, W. W., Kokkotou, E., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m413687200 · Cited by 127
Histone deacetylases and epigenetic therapies of hematological malignancies
Mercurio, C., Minucci, S., & Pelicci, P. G. (2010) · Pharmacological Research · doi:10.1016/j.phrs.2010.02.010 · Cited by 134
Chemical regulation of epigenetic modifications: Opportunities for new cancer therapy
Zheng, Y. G., Wu, J., Chen, Z., & Goodman, M. (2008) · Medicinal Research Reviews · doi:10.1002/med.20120 · Cited by 123
“216 The unique deacetylase HDAC11 has been classified to the new Class IV of HDACs.(217) Histone deacetylase proteins play critical roles in chromatin remodeling and are involved in a multitude of biological processes such as transcription regulation, cell-cycle progression, cell survival and differentiation.”
InfluentialMadsen, A. S., & Olsen, C. A. (2012) · Angewandte Chemie International Edition · doi:10.1002/anie.201203754 · Cited by 122
HDAC3 and the molecular brake pad hypothesis
McQuown, S. C., & Wood, M. A. (2011) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2011.04.005 · Cited by 139
The promise and perils of HDAC inhibitors in neurodegeneration
Didonna, A., & Opal, P. (2015) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.147 · Cited by 118
“29–34 Their cytoplasmic substrates include myeloproliferative leukemia oncogene (MPL) and DNAJB8 – both deacetylated by HDAC4, tripartite motif-containing protein 29 (TRIM29) and heat shock protein 70 (HSP70), substrates of HDAC9 and HDAC10, respectively.34–37 The Class III NAD+-dependent HDACs – called sirtuins, beca…”
BackgroundProtein Acetylation in the Cardiorenal Axis: The Promise of Histone Deacetylase Inhibitors
Bush, E. W., & McKinsey, T. A. (2010) · Circulation Research · doi:10.1161/circresaha.109.209338 · Cited by 121
The application of histone deacetylases inhibitors in glioblastoma
Chen, R., Zhang, M., Zhou, Y., Guo, W., Yi, M., Zhang, Z., Ding, Y., & Wang, Y. (2020) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-020-01643-6 · Cited by 133
Sahakian, E., Powers, J. J., Chen, J., Deng, S. L., Cheng, F., Distler, A., Woods, D. M., Rock-Klotz, J., Sodre, A. L., Youn, J.-I., et al. (2015) · Molecular Immunology · doi:10.1016/j.molimm.2014.08.002 · Cited by 119
Wang, Z., Leng, Y., Wang, J., Liao, H.-M., Bergman, J. A., Leeds, P. R., Kozikowski, A. P., & Chuang, D. (2016) · Scientific Reports · doi:10.1038/srep19626 · Cited by 127
HDAC11 plays an essential role in regulating OX40 ligand expression in Hodgkin lymphoma
Buglio, D., Khaskhely, N. M., Voo, K. S., Martinez-Valdez, H., Liu, Y.-J., & Younes, A. (2011) · Blood · doi:10.1182/blood-2010-08-303701 · Cited by 117
Myogenin regulates a distinct genetic program in adult muscle stem cells
Meadows, E., Cho, J.-H., Flynn, J. M., & Klein, W. H. (2008) · Developmental Biology · doi:10.1016/j.ydbio.2008.07.024 · Cited by 118
Tip60 Is a Co-repressor for STAT3
Xiao, H., Chung, J., Kao, H.-Y., & Yang, Y.-C. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m210816200 · Cited by 117
Terova, G., Díaz, N., Rimoldi, S., Ceccotti, C., Gliozheni, E., & Piferrer, F. (2016) · PLoS ONE · doi:10.1371/journal.pone.0160332 · Cited by 128
“These genes included: dicer 1, which encodes an active, small RNA component that represses the expression of other genes [37]; ehmt2 (euchromatic histone-lysine-N-methyltransferase 2), which demethylates Lys9 in histone 3 in euchromatin, creating a tag for epigenetic transcription repression [38,39]; pcgf2 (polycomb g…”
BackgroundKetogenic Diet: A New Light Shining on Old but Gold Biochemistry
Longo, R., Peri, C., Cricrì, D., Coppi, L., Caruso, D., Mitro, N., Fabiani, E. D., & Crestani, M. (2019) · Nutrients · doi:10.3390/nu11102497 · Cited by 137
“Little is known about the function of HDAC11, the single member of class IV HDAC in mammals [23].”
BackgroundTargeting histone acetylation in pulmonary hypertension and right ventricular hypertrophy
Chelladurai, P., Boucherat, O., Stenmark, K. R., Kracht, M., Seeger, W., Bauer, U., Bonnet, S., & Pullamsetti, S. S. (2019) · British Journal of Pharmacology · doi:10.1111/bph.14932 · Cited by 123
HDAC11: a rising star in epigenetics
Liu, S.-S., Wu, F., Jin, Y.-M., Chang, W. Q., & Xu, T.-M. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110607 · Cited by 112
Kurtev, V., Margueron, R., Kroboth, K., Ogris, E., Cavaillès, V., & Seiser, C. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m312300200 · Cited by 120
Senger, J., Melesina, J., Marek, M., Romier, C., Oehme, I., Witt, O., Sippl, W., & Jung, M. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b01493 · Cited by 112
“In nucleus it was found in protein complexes with HDAC11.(7) It consists of 1216 aa and is the only HDAC which has two functional catalytic domains(8).”
BackgroundNutritionally-Induced Catch-Up Growth
Gat‐Yablonski, G., & Phillip, M. (2015) · Nutrients · doi:10.3390/nu7010517 · Cited by 136
“and -8); class II, subdivided into class IIa (HDAC4, -5, -7 and 9) and class IIb (HDAC6 and -10); and class IV (HDAC11) [196–198]—and seven nicotinamide adenine dinucleotide (NAD+)-dependent HDACs, which comprise class III (sirtuin 1 to -7).”
BackgroundHDAC11 is a novel drug target in carcinomas
Deubzer, H. E., Schier, M. C., Oehme, I., Lodrini, M., Haendler, B., Sommer, A., & Witt, O. (2013) · International Journal of Cancer · doi:10.1002/ijc.27876 · Cited by 112
“HDAC11 is the most recently identified zinc-dependent HDAC family member and has little homology to the other classical HDACs belonging to classes I (HDAC1, HDAC2, HDAC3 and HDAC8), IIa (HDAC4, HDAC5, HDAC7 and HDAC9) and IIb (HDAC6 and HDAC10).(13) Phylogenetic analyses revealed that it is most closely related to bot…”
InfluentialLiu, H., Hu, Q., D'ercole, A. J., & Ye, P. (2009) · Glia · doi:10.1002/glia.20729 · Cited by 110
“In both humans (Gao et al., 2002) and mice (Liu et al., 2008), high levels of HDAC 11 are expressed only in a few of organs, including brain, heart, and kidney, suggesting a specialized function for HDAC 11 in these organs.”
BackgroundResultInfluentialTargeting post-translational histone modifying enzymes in glioblastoma
Kunadis, E., Lakiotaki, E., Korkolopoulou, P. A., & Piperi, C. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2020.107721 · Cited by 116
Lysine Deacetylase Inhibitors in Parasites: Past, Present, and Future Perspectives
Hailu, G. S., Robaa, D., Forgione, M., Sippl, W., Rotili, D., & Mai, A. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b01595 · Cited by 103
HDAC11 is a regulator of diverse immune functions
Yanginlar, C., & Logie, C. (2017) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2017.12.002 · Cited by 124
Fessler, E., Chibane, F., Wang, Z., & Chuang, D.-M. (2013) · Current Pharmaceutical Design · doi:10.2174/1381612811319280009 · Cited by 105
Differential Histone Deacetylase mRNA Expression Patterns in Amyotrophic Lateral Sclerosis
Janssen, C., Schmalbach, S., Boeselt, S., Sarlette, A., Dengler, R., & Petri, S. (2010) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3181ddd404 · Cited by 100
“It can form complexes with HDAC 6 (11, 12) and is predominantly located in the nucleus.”
BackgroundHypoxia-induced and stress-specific changes in chromatin structure and function
Johnson, A. B., & Barton, M. C. (2007) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2006.10.007 · Cited by 114
Histone deacetylase inhibitors – a new tool to treat cancer
Somech, R., Izraeli, S., & Simon, A. J. (2004) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2004.04.006 · Cited by 109
HDAC inhibitors: A new promising drug class in anti-aging research
Pasyukova, E. G., & Vaiserman, A. M. (2017) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2017.08.008 · Cited by 99
Histone/protein deacetylase 11 targeting promotes Foxp3+ Treg function
Huang, J., Wang, L., Dahiya, S., Beier, U. H., Han, R., Samanta, A., Bergman, J., Sotomayor, E. M., Seto, E., Kozikowski, A. P., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-09211-3 · Cited by 96
MYCN and HDAC2 cooperate to repress miR-183 signaling in neuroblastoma
Lodrini, M., Oehme, I., Schroeder, C., Milde, T., Schier, M. C., Kopp-Schneider, A., Schulte, J. H., Fischer, M., De Preter, K., Pattyn, F., et al. (2013) · Nucleic Acids Research · doi:10.1093/nar/gkt346 · Cited by 96
Thaler, F., & Mercurio, C. (2014) · ChemMedChem · doi:10.1002/cmdc.201300413 · Cited by 95
Discovery of histone deacetylase 8 selective inhibitors
Tang, W., Luo, T., Greenberg, E. F., Bradner, J. E., & Schreiber, S. L. (2011) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2011.01.134 · Cited by 92
HDAC1 and HDAC2 in mouse oocytes and preimplantation embryos: Specificity versus compensation
Ma, P., & Schultz, R. M. (2016) · Cell Death and Differentiation · doi:10.1038/cdd.2016.31 · Cited by 100
“Class III HDACs, or sirtuins (SIRT1-7), are homologous with the yeast SIRT2 family of proteins and require NAD+ as a cofactor.14 The subcellular distribution and pattern of tissue-specific expression of this class are unknown.9,15,16 HDAC11, the only member of class IV, is homologous to both class I and class II HDACs…”
BackgroundInfluentialAltered interaction of HDAC5 with GATA-1 during MEL cell differentiation
Watamoto, K., Towatari, M., Ozawa, Y., Miyata, Y., Okamoto, M., Abe, A., Naoe, T., & Saito, H. (2003) · Oncogene · doi:10.1038/sj.onc.1206902 · Cited by 103
“The members of this family are generally large (except for the recently reported HDAC11; Gao et al., 2002), ranging in size from about 650 to 1200 amino acids and these enzymes are considered to shuttle actively between the nucleus and the cytoplasm (Wade, 2001).”
BackgroundWill broad-spectrum histone deacetylase inhibitors be superseded by more specific compounds?
Karagiannis, T. C., & El‐Osta, A. (2006) · Leukemia · doi:10.1038/sj.leu.2404464 · Cited by 106
Chen, Y., Zang, X., Pan, J., Zhu, X., Chen, F., Chen, Z., & Xu, Y. (2012) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2012.05729.x · Cited by 96
“To validate our hypothesis that selective HDAC inhibition may exert neuroprotection in experimental ischaemic stroke, we used an shRNA approach to specifically knockdown HDAC3 or HDAC6.”
BackgroundInfluentialHowell, P., Liu, S., Ren, S., Behlen, C., Fodstad, Ø., & Riker, A. I. (2009) · Cancer Control · doi:10.1177/107327480901600302 · Cited by 100
Shi, L., Miao, Y., Ouyang, Y., Huang, J., Lei, Z., Yang, J., Han, Z., Song, X., Sun, Q., & Chen, D. (2008) · Developmental Dynamics · doi:10.1002/dvdy.21450 · Cited by 92
“Histone acetylation has the greatest potential for unfolding chromatin to recruit different transcriptional factors, and thus acetylation is related to the active genes, and removal of acetylated groups by histone deacetylases (HDACs) is generally associated with gene silencing (Gao et al., 2002; Adcock and Lee, 2006).”
BackgroundHDAC4 Controls Muscle Homeostasis through Deacetylation of Myosin Heavy Chain, PGC-1α, and Hsc70
Luo, L., Martin, S. C., Parkington, J., Cadena, S. M., Zhu, J., Ibebunjo, C., Summermatter, S., Londraville, N., Patora-Komisarska, K., Widler, L., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.09.023 · Cited by 90
Acetylation of proteins as novel target for antitumor therapy: Review article
Gennaro, E. D., Bruzzese, F., Caraglia, M., Abruzzese, A., & Budillon, A. (2004) · Amino Acids · doi:10.1007/s00726-004-0087-3 · Cited by 94
“and Ekstrom, 2001) and the recently discovered HDAC11 (Gao et al., 2002).”
BackgroundFoglietti, C., Filocamo, G., Cundari, E., De Rinaldis, E., Lahm, A., Cortese, R., & Steinkühler, C. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m511945200 · Cited by 90
Histone Deacetylases as Transcriptional Activators? Role Reversal in Inducible Gene Regulation
Nusinzon, I., & Horvath, C. M. (2005) · Science's STKE · doi:10.1126/stke.2962005re11 · Cited by 90
“In addition, a unique deacetylase, HDAC11, has been recently identified (14).”
BackgroundAcetylation- and Methylation-Related Epigenetic Proteins in the Context of Their Targets
Javaid, N., & Choi, S. (2017) · Genes · doi:10.3390/genes8080196 · Cited by 104
“HDAC11 is most relevant to class I, but has not yet been placed in any class because of overall sequence variation [146].”
BackgroundPontiki, E. A., & Hadjipavlou‐Litina, D. (2010) · Medicinal Research Reviews · doi:10.1002/med.20200 · Cited by 91
“Class IV HDACs is represented by HDAC11, which contains conserved residues of the catalytic core region shared by both class I and II enzymes.(23,24) A.”
BackgroundRole of histone deacetylases in vascular cell homeostasis and arteriosclerosis
Zhou, B., Margariti, A., Zeng, L., & Xu, Q. (2011) · Cardiovascular Research · doi:10.1093/cvr/cvr003 · Cited by 93
Developmental expression of histone deacetylase 11 in the murine brain
Liu, H., Hu, Q., Kaufman, A., D'Ercole, A. J., & Ye, P. (2008) · Journal of Neuroscience Research · doi:10.1002/jnr.21521 · Cited by 87
“These findings are consistent with our mRNA abundance data and with a previous report that showed nuclear localization of HDAC11 and low expression of HDAC11 in the liver and lung of human (Gao et al., 2002).”
BackgroundResultInfluentialTherapeutic Strategies to Enhance the Anticancer Efficacy of Histone Deacetylase Inhibitors
Miller, C. P., Singh, M. M., Rivera-Del Valle, N., Manton, C. A., & Chandra, J. (2011) · BioMed Research International · doi:10.1155/2011/514261 · Cited by 86
“HDAC 11 is the sole class IV member and resides in the nucleus [4].”
BackgroundLee, H., Sengupta, N., Villagra, A., Rezai-Zadeh, N., & Seto, E. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.01971-05 · Cited by 86
“Based on similarity to yeast proteins, human HDACs can be divided into three different groups.”
BackgroundInfluentialAntimalarial Activity of the Anticancer Histone Deacetylase Inhibitor SB939
Sumanadasa, S. D. M., Goodman, C. D., Lucke, A. J., Skinner‐Adams, T. S., Sahama, I., Haque, A., Do, T. A., McFadden, G. I., Fairlie, D. P., & Andrews, K. T. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00030-12 · Cited by 89
“Mammalian HDACs are classified into four classes (29, 31).”
BackgroundLiu, C.-J., Prazak, L., Fajardo, M., Yu, S., Tyagi, N., & Cesare, P. E. D. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m405288200 · Cited by 86
Host, L., Dietrich, J.-B., Carouge, D., Aunis, D., & Zwiller, J. (2011) · Journal of Psychopharmacology · doi:10.1177/0269881109348173 · Cited by 86
“HDAC11 is the only class IV HDAC (Gao et al., 2002).”
BackgroundHistone deacetylases in fungi: novel members, new facts
Trojer, P. (2003) · Nucleic Acids Research · doi:10.1093/nar/gkg473 · Cited by 86
“Within the past 2 years the number of human class 1 and class 2 HDACs rose from 5 to 11 (47).”
BackgroundActivity-Guided Design of HDAC11-Specific Inhibitors
Son, S. I., Cao, J., Zhu, C.-L., Miller, S. P., & Lin, H. (2019) · ACS Chemical Biology · doi:10.1021/acschembio.9b00292 · Cited by 74
Role of histone deacetylases and their inhibitors in neurological diseases
Zhang, L.-Y., Zhang, S.-Y., Wen, R., Zhang, T.-N., & Yang, N. (2024) · Pharmacological Research · doi:10.1016/j.phrs.2024.107410 · Cited by 84
Acetylation/Deacetylation Modulates the Stability of DNA Replication Licensing Factor Cdt1
Glozak, M. A., & Seto, E. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m809394200 · Cited by 82
Fournel, M., Trachy-Bourget, M.-C., Yan, P. T., Kalita, A., Bonfils, C., Beaulieu, C., Fréchette, S., Leit, S. M., Abou-Khalil, E., Woo, S.-H., et al. (2002) · PubMed · Cited by 94
Núñez‐Álvarez, Y., & Suelves, M. (2021) · FEBS Journal · doi:10.1111/febs.15895 · Cited by 94
Schepper, S. D., Bruwiere, H., Verhulst, T., Steller, U., Andries, L. J., Wouters, W., Janicot, M., Arts, J., & Heusden, J. V. (2003) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.042903 · Cited by 89
“Class I is related to yeast Rpd3 and contains HDAC1, HDAC2, HDAC3, HDAC8, and the recently cloned HDAC11 (Gray and Ekstrom, 2001; Gao et al., 2002).”
BackgroundA Novel Corepressor, BCoR-L1, Represses Transcription through an Interaction with CtBP
Pagan, J. K., Arnold, J., Hanchard, K. J., Kumar, R., Bruno, T., Jones, M. J. K., Richard, D. J., Forrest, A., Spurdle, A., Verdin, E., et al. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m700246200 · Cited by 81
Changes in histone modifications during in vitro maturation of porcine oocytes
Endo, T., Naito, K., Aoki, F., Kume, S., & Tojo, H. (2005) · Molecular Reproduction and Development · doi:10.1002/mrd.20288 · Cited by 87
“At present, elevenHDACs in three classes have been reported in mammals (Gao et al., 2002; Tong et al., 2002).”
BackgroundHistone deacetylase 11 inhibition promotes breast cancer metastasis from lymph nodes
Leslie, P. L., Chao, Y. L., Tsai, Y.-H., Ghosh, S. K., Porrello, A., Van Swearingen, A. E. D., Harrison, E. B., Cooley, B. C., Parker, J. S., Carey, L. A., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-12222-5 · Cited by 80
Histone deacetylases: Focus on the nervous system
Morrison, B. E., Majdzadeh, N., & D’Mello, S. R. (2007) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-007-7035-9 · Cited by 93
Histone Deacetylase Inhibitors as Therapeutic Agents for Acute Central Nervous System Injuries
Shein, N. A., & Shohami, E. (2011) · Molecular Medicine · doi:10.2119/molmed.2011.00038 · Cited by 85
“Finally, class IV consists of a single member, HDAC 11, which shares certain characteristics with class I and class II HDACs, but has been suggested to facilitate different physiological roles (30).”
BackgroundLee, J., Jeong, E.-G., Choi, M.-C., Kim, S.-H., Park, J., Song, S., Park, J., Bang, Y., & Kim, T.-Y. (2010) · Molecules and Cells · doi:10.1007/s10059-010-0094-z · Cited by 87
“Class III HDACs (silent information regulators [SIRTs1-7]) are NAD+-dependent enzymes which are related to yeast SIR2, and HDAC11 is a Class IV HDAC (Gao et al., 2002; Gray and Ekstrom, 2001).”
BackgroundHDAC inhibitor therapy in autoimmunity and transplantation
Hancock, W. W., Akimova, T., Beier, U. H., Liu, Y., & Wang, L. (2012) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2011-200593 · Cited by 80
Huang, W., Wang, Y., Chao, S., Yang, C., Chen, L., Lin, M., Hou, W., Chen, M., Lee, T., Yang, P., et al. (2012) · ChemMedChem · doi:10.1002/cmdc.201200300 · Cited by 76
Substrate and inhibitor specificity of class 1 and class 2 histone deacetylases
Hildmann, C., Wegener, D., Riester, D., Hempel, R., Schober, A., Merana, J., Giurato, L., Guccione, S., Nielsen, T. K., Ficner, R., et al. (2006) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2006.01.030 · Cited by 77
Koeneke, E., Witt, O., & Oehme, I. (2015) · Cells · doi:10.3390/cells4020135 · Cited by 75
“Class IV has a single member, HDAC11, whose structure bears some resemblance to Classes I and II HDACs, but is not similar enough to be placed in either class [8,102,103].”
BackgroundDing, Z., Gillespie, L. L., & Paterno, G. D. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.1.250-258.2003 · Cited by 77
“Eleven human HDACs have been identified (7, 10, 11, 13, 17, 19, 34, 42) and have been divided into three classes based on their homology to Saccharomyces cerevisiae proteins (5, 8, 9, 12, 28, 31, 36), and it is believed that the different HDACs may have unique temporal and spatial expression patterns that con-”
BackgroundComplex neuroprotective and neurotoxic effects of histone deacetylases
Thomas, E. A., & D'Mello, S. R. (2018) · Journal of Neurochemistry · doi:10.1111/jnc.14309 · Cited by 74
“HDAC11 is the sole member of class IV, and while sharing similar characteristics with HDACs in classes I and II, HDAC 11 is thought to differ in its physiological properties (Gao et al. 2002; Yang and Seto 2008).”
BackgroundRole of histone acetylation in cell physiology and diseases: An update
Khan, S. N., & Khan, A. U. (2010) · Clinica Chimica Acta · doi:10.1016/j.cca.2010.06.020 · Cited by 92
Keynote review: Chromatin control and cancer-drug discovery: realizing the promise
Inche, A. G., & Thangue, N. B. L. (2006) · Drug Discovery Today · doi:10.1016/s1359-6446(05)03691-3 · Cited by 88
Adhikari, N., Amin, S. A., Trivedi, P., Jha, T., & Ghosh, B. (2018) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2018.08.081 · Cited by 74
Metadata
- Authors
- Gao, L., Cueto, M. A., Asselbergs, F., & Atadja, P.
- Affiliations
- Novartis (United States) (US)
- Corresponding author
- Atadja, Peter
- ORCID
- Gao, Lin
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2002-07
- Volume
- 277
- Issue
- 28
- Pages
- 25748-25755
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2070089404
- Cited by
- 744
- References
- 43
- Citations by year
- 2026: 27 · 2025: 28 · 2024: 32 · 2023: 36 · 2022: 31 · 2021: 33 · 2020: 43 · 2019: 26 · 2018: 30 · 2017: 36 · 2016: 30 · 2015: 41 · 2014: 34 · 2013: 30 · 2012: 37
- FWCI
- 8.48
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 6687 d)
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Histone Deacetylase Inhibitors Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
- Keywords
- HDAC11, histone deacetylase, cDNA cloning, histone deacetylase activity, tissue expression, nuclear localization, protein complexes, evolutionary conservation
- MeSH terms
- Amino Acid Sequence, Animals, Base Sequence, Cloning, Molecular, Histone Deacetylases, Humans, Molecular Sequence Data, Nuclear Proteins, RNA, Messenger, Sequence Homology, Amino Acid, DNA, Complementary
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.